Tetanolysin
WikiDoc Resources for Tetanolysin |
Articles |
---|
Most recent articles on Tetanolysin Most cited articles on Tetanolysin |
Media |
Powerpoint slides on Tetanolysin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tetanolysin at Clinical Trials.gov Clinical Trials on Tetanolysin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tetanolysin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tetanolysin Discussion groups on Tetanolysin Patient Handouts on Tetanolysin Directions to Hospitals Treating Tetanolysin Risk calculators and risk factors for Tetanolysin
|
Healthcare Provider Resources |
Causes & Risk Factors for Tetanolysin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Tetanolysin is a toxin produced by Clostridium tetani bacteria.
Clostridium tetani, the causative agent of the disease tetanus, produces two exotoxins, tetanolysin and tetanospasmin. The function of tetanolysin is not known with certainty but there is data that suggests tetanolysin may contribute to the pathogenesis of tetanus.
Tetanolysin belongs to a family of protein toxins known as cytolysins which bind to cholesterol. Cytolysins form pores in the cytoplasmic membrane that allows for the passage of ions and other molecules into the cell. The molecular weight of Tetanolysin is approximately 55,000 daltons.[1]
References
- Alouf, J. (1997) pp 7-10 in Guidebook to Protein Toxins and Their Use in Cell Biology, Ed. Rappuoli, R. and Montecucco, C. (Oxford University Press).
- Ahnert-Hilger, G., Pahner, I., and Höltje, M. (1999) Pore-forming Toxins as Cell Biological and Pharmacological Tools. In press.
- Conti, A., Brando, C., DeBell, K.E., Alava, M.A., Hoffman, T., Bonvini, E. (1993) J. Biol. Chem. 268, 783-791.
- Raya, S.A., Trembovler, V., Shohami, E. and Lazarovici, P. (1993) Nat. Toxins 1, 263-70.